• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Patient Derived Xenograft Model Companies

    ID: MRFR/HC/10607-HCR
    128 Pages
    Rahul Gotadki
    September 2025

    Patient-Derived Xenograft (PDX) models have emerged as invaluable tools in preclinical cancer research, providing a bridge between traditional in vitro studies and human clinical trials. These models involve implanting patient tumor samples directly into immunodeficient mice, allowing researchers to study tumor behavior, response to treatments, and potential therapeutic strategies in a more clinically relevant setting. 

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Patient Derived Xenograft Model Market Research Report 2034 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Patient Derived Xenograft Model Market

    Patient Derived Xenograft Model Key Companies

     


    Latest Patient Derived Xenograft Model Companies Update:

    Emulate Inc. partners with MD Anderson Cancer Center to develop advanced PDX models for personalized medicine: This collaboration combines Emulate's Organ-on-a-Chip technology with MD Anderson's expertise in PDX models to create personalized tumor microenvironments for drug testing and treatment response prediction.


    Charles River Laboratories acquires Oncodesign, expanding its global PDX capabilities: This acquisition strengthens Charles River's position as a leading provider of PDX models and related services, offering broader access to diverse tumor types and expertise.


    XenTech and Transgene announce a strategic partnership to develop and commercialize novel PDX models for immuno-oncology research: This collaboration harnesses XenTech's humanized mouse immune system platform with Transgene's extensive PDX library to create models that accurately predict the efficacy of immuno-oncology drugs.


    List of Patient Derived Xenograft Model Key companies in the market


    • Charles River Laboratories




    • The Jackson Laboratory




    • Crown Bioscience




    • Altogen Labs




    • Envigo




    • WuXi AppTec




    • Oncodesign




    • Hera Biolabs




    • XenTech




    • Abnova Corp.